Production of alpha 1,3-Galactosyltransferase gene-deficient pigs by somatic cell nuclear transfer: A novel selection method for gal alpha 1,3-Gal antigen-deficient cells-Reference-Cited by-同舟云学术

Production of alpha 1,3-Galactosyltransferase gene-deficient pigs by somatic cell nuclear transfer: A novel selection method for gal alpha 1,3-Gal antigen-deficient cells

Published:2008-09 Issue:9 Volume:75 Page:1372-1378
ISSN:1040-452X
Container-title:Molecular Reproduction and Development
language:en
Short-container-title:Mol. Reprod. Dev.

Author:

Fujimura Tatsuya,Takahagi Yoichi,Shigehisa Tamotsu,Nagashima Hiroshi,Miyagawa Shuji,Shirakura Ryota,Murakami Hiroshi

Publisher

Wiley

Subject

Cell Biology,Developmental Biology,Genetics

Reference27 articles.

1. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs;Dai;Nat Biotechnol,2002

2. Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast;Datta;Proc Natl Acad Sci USA,1997

3. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation;Eggan;Proc Natl Acad Sci USA,2001

4. Cloning of the transgenic pigs expressing human decay accelerating factor and N-acetylglucosaminyltransferase III;Fujimura;Cloning Stem Cells,2004

5. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1-3Gal epitope in primates;Galili;Proc Natl Acad Sci USA,1987

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the CRISPR/Cas3 System for Xenotransplantation;Transplantation Proceedings;2022-03

2. Generation of cattle knockout for galactose‐α1,3‐galactose and N‐glycolylneuraminic acid antigens;Xenotransplantation;2019-05-22

3. Porcine pluripotent stem cells: progress, challenges and prospects;Frontiers of Agricultural Science and Engineering;2019

4. Reproduction Biotechnology in Pigs;Advances in Animal Biotechnology;2019

5. Apancreatic pigs cloned using Pdx1-disrupted fibroblasts created via TALEN-mediated mutagenesis;Oncotarget;2017-12-14